ArticleJournal of the American Heart Association2017

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.

Thomas Bonnard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.